AnaptysBio, Inc. announced the appointment of Dominic Piscitelli as chief financial officer. Mr. Piscitelli will play a key role in AnaptysBio's finance strategy, as well as overseeing the company's accounting and SEC reporting functions. Prior to joining AnaptysBio, Mr. Piscitelli served as vice president of finance, strategy and investor relations at Medivation, Inc., and played in a key role in its acquisition by Pfizer. Between 2011 and 2012, Mr. Piscitelli served as senior director of collaborations and operations finance at Astellas Pharmaceuticals.